06/02/2026
Exciting news! Bay Area Lyme Ventures, the impact investment fund created by Bay Area Lyme Foundation, has made a strategic investment in Galaxy Diagnostics a company dedicated to advancing innovative testing for Lyme disease and other vector-borne illnesses. This investment reflects our commitment to helping promising scientific discoveries move from the research lab to the clinic.
FOR IMMEDIATE RELEASE Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing Partnership Aims to Accelerate Innovation in Diagnostic Tools for Patients with Complex Tick and Vector-Borne Illnesses DURHAM, NC., June 2, 2026 – Galaxy Diagnostics, a leader in ad....